Publication|Articles|September 19, 2025
- Pharmaceutical Executive: September 2025
- Volume 45
- Issue 7
Pharmaceutical Executive: September 2025 Interactive Digital Edition
View the Pharmaceutical Executive September 2025 issue in an interactive format.
Advertisement
Click
Articles in this issue
about 1 month ago
Can AI Point the Way?about 1 month ago
Turning AI Pilots into Enterprise Valueabout 1 month ago
Paul Hudson: A Mindset for Miraclesabout 1 month ago
How AI is Shaping KOL and DOL Identificationabout 1 month ago
From Lab to Market: Tracking Today’s Shifting Pathways for Biotechabout 1 month ago
Beyond the Pitch: Tapping Synergies in Earned Media Engagementabout 1 month ago
What Innovation in PBM Management Really Looks Likeabout 1 month ago
Measuring the ROI of SPP Adherence ProgramsNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Investors Have Questions About GLP-1 Drug Prices Ahead of Eli Lilly and Novo Quarterly Statements: Report
2
Thermo Fisher Enters $8.8 Billion Definitive Agreement to Acquire Clario Holdings
3
FDA Announces New Biosimilar-Targeted Draft Guidance
4
AI Built for Pharma—Out-of-the-Box Wins on Time, Risk, and ROI
5
